Senior insider sale
LIGAND PHARMACEUTICALS INC — senior position signals high conviction
$342.0K
1.20K shares
What this filing means
ZIMMERMANN MARTINE plans to sell 1.20K shares of LIGAND PHARMACEUTICALS INC valued at approximately $342.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/10/2026ACC: 0001950047-26-009263
Director
Since Sep 2023
1.20K
Shares to sell
$342.0K
Approx. market value
1.20K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months2
Restricted Stock
Not Applicable
6/6/2025
438.00Restricted Stock
Not Applicable
9/22/2024
762.00Total acquired1.20K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
6/6/2025 | Restricted Stock Not Applicable | 438.00 | — |
9/22/2024 | Restricted Stock Not Applicable | 762.00 | — |
| Total | 1.20K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
1.20K
Market value
$342.0K
9/10/2026
Total
Units
1.20K
Value
$342.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
9/10/2026 | 1.20K | $342.0K | NASDAQ | Planned |
| Total | 1.20K | $342.0K | ||